Follow the TC BioPharm (Holdings) plc share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 11 January 2023 (Acquisition). Among the most active insiders: Randall Kenneth Edward. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€2m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,803 shares@ US$1.153.2% of flowOrdinary Shares [ADS]SEC:0001929926-22-000002:0
Canonical exit: 22 Aug 2022 (T+90)
7 of 7 declarations
About TC BioPharm (Holdings) plc
TC BioPharm (Holdings) plc is a biopharmaceutical company focused on developing cell therapies for the treatment of cancer and other diseases. It is listed on NASDAQ.